Related references
Note: Only part of the references are listed.Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cells
Ian R. Logan et al.
PROSTATE (2007)
Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma
Elias Drakos et al.
CLINICAL CANCER RESEARCH (2007)
Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma
Tom Van Maerken et al.
CANCER RESEARCH (2006)
Effect of an hdm-2 antagonist peptide inhibitor on cell cycle progression in p53-deficient H1299 human lung carcinoma cells
A. VanderBorght et al.
ONCOGENE (2006)
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)
Paola Secchiero et al.
BLOOD (2006)
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells
Llorenc Coll-Mulet et al.
BLOOD (2006)
Regulation of class II β-tubulin expression by tumor suppressor p53 protein in mouse melanoma cells in response to Vinca alkaloid
K Arai et al.
MOLECULAR CANCER RESEARCH (2006)
Drug therapy - Treatment of acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival
B Györffy et al.
ONCOGENE (2005)
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma
T Stühmer et al.
BLOOD (2005)
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
K Kojima et al.
BLOOD (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
In vitro drug sensitivity and apoptosis induction in newly diagnosed pediatric acute lymphoblastic leukemia: Correlation with overall survival
G Srinivas et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2004)
Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression
G Urban et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells
MX Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
A Mirza et al.
ONCOGENE (2002)
Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism
E Lorenzo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Transcriptional repression of the anti-apoptotic survivin gene by wild type p53
WH Hoffman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The IARC TP53 database: New Online mutation analysis and recommendations to users
M Olivier et al.
HUMAN MUTATION (2002)
MDM2 and p53 in childhood acute lymphoblastic leukemia: Higher expression in childhood leukemias with poor prognosis compared to long-term survivors
B Gustafsson et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2001)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia
M Zhou et al.
LEUKEMIA (2000)
Share Paper
